TRACON PHARMACEUTICALS, INC. SEVERANCE PLAN AMENDED AND RESTATED SEVERANCE AGREEMENTSeverance Agreement • March 8th, 2023 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This Amended and Restated Severance Agreement (the "Agreement") is entered into by and between Bonne Adams ("you" or "your") and TRACON Pharmaceuticals, Inc. (the "Company") pursuant to the TRACON Pharmaceuticals, Inc. Severance Plan ("Plan"). Capitalized terms used herein but not otherwise defined have the meanings set forth in the Plan.
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 8th, 2023 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This First Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of December 22, 2022, by and among TRACON PHARMACEUTICALS, INC., a Delaware corporation (“Borrower Representative”), and each other Person party to the Loan Agreement (as defined below) as a borrower from time to time (individually and collectively, jointly and severally, “Borrower”), the lenders from time to time party to the Loan Agreement (collectively, “Lenders”, and each, a “Lender”), and RUNWAY GROWTH FINANCE CORP., as administrative agent and collateral agent for Lenders (in such capacity, “Agent”).
TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2023 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the "Agreement") is made and entered into effective as of February 27, 2017 (the "Effective Date"), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Bonne Adams (the "Executive"). The Company and Executive are hereinafter collectively referred to as the "Parties", and individually referred to as a "Party". From and following the Effective Date, this Agreement along with the Amended and Restated Severance Agreement entered into by and between Executive and the Company concurrently with this Agreement (the "Amended Severance Agreement') shall replace and supersede that certain Employment Agreement between Executive and Company entered into as of August 23, 2006 and amended as of March 25, 2011 and Severance Agreement between the Company and Executive dated June 2, 2014 (collectively, the "Prior Agreement"). Certain capitalized terms used in this Agreement are defined in Section 11.
ContractInvestment Agreement • March 8th, 2023 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
